LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 73 filers reported holding LEGEND BIOTECH CORP in Q1 2021. The put-call ratio across all filers is 3.21 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $114,760,617 | +96.0% | 1,708,510 | +101.5% | 0.26% | +104.7% |
| Q2 2023 | $58,544,343 | +147.8% | 848,100 | +46.5% | 0.13% | +115.3% |
| Q3 2022 | $23,625,000 | -64.2% | 579,052 | -51.7% | 0.06% | -60.9% |
| Q2 2022 | $66,000,000 | +124.2% | 1,200,000 | +48.1% | 0.15% | +169.6% |
| Q1 2022 | $29,435,000 | +37.3% | 810,000 | +76.1% | 0.06% | +43.6% |
| Q4 2021 | $21,441,000 | +69.6% | 460,000 | +84.0% | 0.04% | +56.0% |
| Q3 2021 | $12,640,000 | -66.5% | 250,000 | -80.8% | 0.02% | -67.5% |
| Q1 2021 | $37,726,000 | -33.0% | 1,300,000 | -35.0% | 0.08% | -37.4% |
| Q4 2020 | $56,320,000 | +5.6% | 2,000,000 | +15.8% | 0.12% | -7.5% |
| Q3 2020 | $53,321,000 | +21.0% | 1,727,267 | +66.9% | 0.13% | +17.7% |
| Q2 2020 | $44,057,000 | – | 1,035,172 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
| Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
| HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
| RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
| Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
| Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
| E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
| Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
| Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |